Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.16
+0.51 (2.07%)
At close: Aug 13, 2025, 4:00 PM
25.07
-0.09 (-0.36%)
Pre-market: Aug 14, 2025, 9:17 AM EDT
Pfizer Revenue
Pfizer had revenue of $14.65B in the quarter ending June 29, 2025, with 10.31% growth. This brings the company's revenue in the last twelve months to $63.83B, up 13.53% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$63.83B
Revenue Growth
+13.53%
P/S Ratio
2.24
Revenue / Employee
$788,062
Employees
81,000
Market Cap
143.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
| Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
| Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
| Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
| Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
PFE News
- 17 hours ago - July Readers Tagged 9 Ideal Dividend Dogs From 17 "Safer" Of 40 ReFa/Ro Mentions - Seeking Alpha
- 23 hours ago - FDA may revoke Pfizer COVID-19 vaccine authorization for kids under certain age - Fox Business
- 1 day ago - FDA may pull authorization of Pfizer's Covid vaccine for children under 5 - CNBC
- 2 days ago - Pfizer's combination therapy improves survival in bladder cancer trial - Reuters
- 2 days ago - PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery - Business Wire
- 2 days ago - FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply - Benzinga
- 6 days ago - CureVac settles patent dispute litigation with Pfizer and BioNTech - Reuters
- 7 days ago - Pfizer's Turnaround Has Truly Started (Earnings Update) - Seeking Alpha